SE417196B - Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer - Google Patents

Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer

Info

Publication number
SE417196B
SE417196B SE7701795A SE7701795A SE417196B SE 417196 B SE417196 B SE 417196B SE 7701795 A SE7701795 A SE 7701795A SE 7701795 A SE7701795 A SE 7701795A SE 417196 B SE417196 B SE 417196B
Authority
SE
Sweden
Prior art keywords
metylamines
propandiols
dioxan
intermediates
preparation
Prior art date
Application number
SE7701795A
Other languages
English (en)
Swedish (sv)
Other versions
SE7701795L (sv
Inventor
R N Booher
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7701795L publication Critical patent/SE7701795L/xx
Publication of SE417196B publication Critical patent/SE417196B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7701795A 1972-12-08 1977-02-17 Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer SE417196B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31322172A 1972-12-08 1972-12-08

Publications (2)

Publication Number Publication Date
SE7701795L SE7701795L (sv) 1977-02-17
SE417196B true SE417196B (sv) 1981-03-02

Family

ID=23214841

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7316586A SE403377B (sv) 1972-12-08 1973-12-07 Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan
SE7701795A SE417196B (sv) 1972-12-08 1977-02-17 Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer
SE7701796A SE428378B (sv) 1972-12-08 1977-02-17 Analogiforfarande for framstellning av droxanderivat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7316586A SE403377B (sv) 1972-12-08 1973-12-07 Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7701796A SE428378B (sv) 1972-12-08 1977-02-17 Analogiforfarande for framstellning av droxanderivat

Country Status (27)

Country Link
JP (2) JPS5742633B2 (xx)
AR (3) AR206306A1 (xx)
AT (2) AT330773B (xx)
BE (1) BE808340A (xx)
BG (4) BG22386A3 (xx)
CA (2) CA1014560A (xx)
CH (4) CH605903A5 (xx)
CS (3) CS222209B2 (xx)
CY (1) CY1017A (xx)
DD (3) DD110864A5 (xx)
DE (1) DE2361340C2 (xx)
DK (1) DK134717B (xx)
ES (4) ES421290A1 (xx)
FR (1) FR2209578B1 (xx)
GB (2) GB1455998A (xx)
HK (1) HK60479A (xx)
HU (2) HU168763B (xx)
IE (1) IE40226B1 (xx)
IL (1) IL43773A (xx)
KE (1) KE2976A (xx)
MY (1) MY8000064A (xx)
NL (1) NL7316839A (xx)
PH (2) PH15197A (xx)
SE (3) SE403377B (xx)
SU (4) SU578001A3 (xx)
YU (3) YU36171B (xx)
ZA (1) ZA739207B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2847177B1 (en) * 2012-05-09 2017-10-11 Boehringer Ingelheim International GmbH Methods for making oxetan-3-ylmethanamines
LV14983B (lv) * 2013-10-15 2015-06-20 Olainfarm, A/S Fenibuta ražošanas starpproduktu iegūšanas paņēmiens

Also Published As

Publication number Publication date
ES444911A1 (es) 1977-09-01
YU35447B (en) 1981-02-28
ZA739207B (en) 1975-07-30
NL7316839A (xx) 1974-06-11
CA1014560A (en) 1977-07-26
DD109625A5 (xx) 1974-11-12
SE7701795L (sv) 1977-02-17
ES421291A1 (es) 1976-07-01
ES421290A1 (es) 1976-07-01
YU318473A (en) 1980-09-25
SE403377B (sv) 1978-08-14
IL43773A (en) 1979-05-31
HU168763B (xx) 1976-07-28
SE7701796L (sv) 1977-02-17
HU168620B (xx) 1976-06-28
CS222209B2 (en) 1983-05-27
IE40226L (en) 1974-06-08
AU6321773A (en) 1975-06-05
FR2209578B1 (xx) 1977-09-02
DE2361340C2 (de) 1983-11-24
JPS5734835B2 (xx) 1982-07-26
ES444716A1 (es) 1977-05-16
DK134717C (xx) 1977-05-31
DD115653A5 (xx) 1975-10-12
GB1455998A (en) 1976-11-17
CS222208B2 (en) 1983-05-27
CH619219A5 (en) 1980-09-15
AR212416A1 (es) 1978-07-14
YU318573A (en) 1981-06-30
DD110864A5 (xx) 1975-01-12
ATA1026173A (de) 1976-01-15
SU587861A3 (ru) 1978-01-05
CH605903A5 (xx) 1978-10-13
PH15197A (en) 1982-09-17
SU648081A3 (ru) 1979-02-15
BG26205A4 (bg) 1979-02-15
CY1017A (en) 1979-11-23
AR206306A1 (es) 1976-07-15
SU663305A3 (ru) 1979-05-15
HK60479A (en) 1979-08-31
ATA1026073A (de) 1975-10-15
BG21409A3 (bg) 1976-05-20
JPS4987680A (xx) 1974-08-22
IL43773A0 (en) 1974-03-14
CA1024150A (en) 1978-01-10
CH614439A5 (en) 1979-11-30
CS193480B2 (en) 1979-10-31
DK134717B (da) 1977-01-03
MY8000064A (en) 1980-12-31
YU36171B (en) 1982-02-25
BE808340A (fr) 1974-06-07
JPS4987681A (xx) 1974-08-22
DE2361340A1 (de) 1974-06-12
YU36020B (en) 1981-11-13
GB1455997A (en) 1976-11-17
SE428378B (sv) 1983-06-27
AT330773B (de) 1976-07-26
IE40226B1 (en) 1979-04-11
YU109380A (en) 1981-04-30
BG21223A3 (bg) 1976-03-20
AT332396B (de) 1976-09-27
KE2976A (en) 1979-07-20
SU578001A3 (ru) 1977-10-25
BG22386A3 (bg) 1977-02-20
PH14923A (en) 1982-01-29
JPS5742633B2 (xx) 1982-09-09
FR2209578A1 (xx) 1974-07-05
AR212012A1 (es) 1978-04-28
CH630914A5 (en) 1982-07-15

Similar Documents

Publication Publication Date Title
SE400280B (sv) 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
SE7710602L (sv) Mellanprodukter for framstellning av bensoxazolderivat
NO139560C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
SE397257B (sv) Forfarande for framstellning av sackaroshaltiga sotningsmedel
IT975971B (it) Procedimento per la preparazione di clorosilani
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE389856B (sv) Forfarande for framstellning av alkaliperkarbonater
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE393808B (sv) Forfarande for framstellning av isomaltit
NO142624C (no) Forbindelser for anvendelse som mellomprodukter for fremstilling av terapeutisk virksomme 4-aminoamfetaminderivater
AR197040A1 (es) Procedimiento de preparacion de nuevas bifenilacetamidas
IT956743B (it) Procedimento per la preparazione di composti alchilsolfonati
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
SE417196B (sv) Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer
IT996099B (it) Procedimento di preparazione di amminoantrachinone
DK555680A (da) Benzocycloptathiophenderivater til anvendelse som mellemprodukter ved fremstilling af terapeutisk virksomme benzocycloptathiophenderivater
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
IT977792B (it) Procedimento per la preparazione di cianidrine